info@biomedres.us
+1 (502) 904-2126
One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA
Site Map
ISSN: 2574 -1241
ISSN: 2574 -1241
Received: October 11, 2017; Published: October 13, 2017
DOI: 10.26717/BJSTR.2017.01.000440
Biomarker discovery in the field of pediatric gastroenterology is necessary so that clinicians can use objective, non-invasive ways to screen for a disease in its preclinical stage, measure disease severity or monitor response to a particular treatment. The utilization of high-throughput analyses, such as with proteomics and metabolomics, allows researchers to quickly investigate numerous methodologies and generate large datasets, while only requiring small quantities of the biological specimen.
Keywords : Biomarker; Proteomics; Metabolomics; High Throughput
Abbreviations : CD: Crohn’s Disease; HC: Healthy Controls
Abstract| Introduction| Pediatric Gastroenterology| Conclusion| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Neurology, LA BioMed Research Institute, USA
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China
Clinical Radiologist (MD) - Department of RADIOLOGY, Cosenza Hospital, Cosenza, Italy
Full Text
PDF
